title: [A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient].
abstract: In recent years, many patients have had to undergo hemodialysis due to chronic renal failure. In addition, the number of hemodialysis patients in whom lung cancer is discovered is increasing. However, a standard chemoradiotherapy regimen for limited-disease small-cell lung cancer patients undergoing maintenance hemodialysis has not yet been established. We administered concurrent chemoradiotherapy using carboplatin 300 mg/m2 (day 1) plus etoposide 50 mg/m2 (day 1, 3). A partial response was achieved after 4 courses of chemotherapy and 68 Gy of radiotherapy. The major toxicities were hematological toxicities; they included grade 4 thrombocytopenia, grade 3 anemia, and neutropenia.
authors.affiliation: Dept. of Respiratory Medicine, Tokyo Dental College Ichikawa General Hospital.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Terashima
authors.forename: Eri
authors.initials: E
authors.lastname: Iwami
authors.forename: Shotaro
authors.initials: S
authors.lastname: Chubachi
authors.forename: Shinnosuke
authors.initials: S
authors.lastname: Ikemura
authors.forename: Takahiro
authors.initials: T
authors.lastname: Nakajima
authors.forename: Tatsu
authors.initials: T
authors.lastname: Matsuzaki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Aoyagi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D059248:Chemoradiotherapy; D003956:Dialysis; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000209:etiology; D055752:Small Cell Lung Carcinoma / Q000628:therapy*
chemical_list: D005047:Etoposide; D016190:Carboplatin